{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:44:01Z","timestamp":1792079041740,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023452","name":"Hanarth Fund Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.modpat.2026.101076","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:29:38Z","timestamp":1788910178000},"page":"101076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histopathologic, Genomic, and Clinical Characteristics of Primary Cutaneous Melanocytic Tumors With Concomitant NRAS Q61 and IDH1 R132C Mutations"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6656-8967","authenticated-orcid":false,"given":"Chiel F.","family":"Ebbelaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerben E.","family":"Breimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke R.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.L.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willeke A.M.","family":"Blokx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.modpat.2026.101076_bib1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.modpat.2026.101076_bib2","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/his.13707","article-title":"Isocitrate dehydrogenase 1 mutations in melanoma frequently co-occur with NRAS mutations","volume":"73","author":"Linos","year":"2018","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.modpat.2026.101076_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2026.101076_bib4","series-title":"Skin Tumours","first-page":"12","year":"2025"},{"issue":"10","key":"10.1016\/j.modpat.2026.101076_bib5","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/PAS.0000000000001500","article-title":"Cutaneous melanocytic tumors with concomitant NRAS Q61R and IDH1 R132C mutations: a report of 6 cases","volume":"44","author":"Macagno","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2026.101076_bib6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41379-022-01026-6","article-title":"Towards diagnostic criteria for malignant deep penetrating melanocytic tumors using single nucleotide polymorphism array and next-generation sequencing","volume":"35","author":"Ebbelaar","year":"2022","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101076_bib7","first-page":"19","article-title":"Pathology databanking and biobanking in the Netherlands: a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell Oncol"},{"key":"10.1016\/j.modpat.2026.101076_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105643","article-title":"Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours","volume":"114","author":"Ebbelaar","year":"2025","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.modpat.2026.101076_bib9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/ng.3382","article-title":"Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway","volume":"47","author":"Shain","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.modpat.2026.101076_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/modpathol.2016.237","article-title":"Spitz nevi and spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas","volume":"30","author":"Lazova","year":"2017","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101076_bib11","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41379-019-0445-z","article-title":"Spitz melanoma is a distinct subset of spitzoid melanoma","volume":"33","author":"Raghavan","year":"2020","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101076_bib12","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.3390\/cancers13123066","article-title":"NGS-based analysis of atypical deep penetrating nevi","volume":"13","author":"Manca","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.modpat.2026.101076_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41467-017-00758-3","article-title":"Combined activation of MAP kinase pathway and \u03b2-catenin signaling cause deep penetrating nevi","volume":"8","author":"Yeh","year":"2017","journal-title":"Nat Commun"},{"issue":"7274","key":"10.1016\/j.modpat.2026.101076_bib14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.modpat.2026.101076_bib15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ajpath.2010.12.011","article-title":"Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation","volume":"178","author":"Shibata","year":"2011","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101076_bib16","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/jid.2013.70","article-title":"Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS","volume":"133","author":"Kinsler","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101076_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/2767-9764.CRC-24-0386","article-title":"Loss of NF1 accelerates uveal and intradermal melanoma tumorigenesis, and oncogenic GNAQ transforms Schwann cells","volume":"5","author":"Longakit","year":"2025","journal-title":"Cancer Res Commun"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:45:57Z","timestamp":1792075557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226001195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0893395226001195"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101076","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathologic, Genomic, and Clinical Characteristics of Primary Cutaneous Melanocytic Tumors With Concomitant NRAS Q61 and IDH1 R132C Mutations","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"101076"}}